Diagnostic Cytopathology Journal Citation Rate 2026
1097-0339
eISSN 8755-1039
Wiley
US
Q3 Quartile Verified Publisher
About Diagnostic Cytopathology
Diagnostic Cytopathology (DC) is a peer-reviewed academic journal covering Breast Lesions and Carcinomas and Cancer and Skin Lesions, published by Wiley in US, catalogued under ISSN 1097-0339 (e-ISSN 8755-1039). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.70 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3550 USD). OpenAlex records 8,677 works and 116,660 citations, with an h-index of 89.
Diagnostic Cytopathology Citation Rate 2026 — In Context
Diagnostic Cytopathology has a 2025 2-Year Citation Rate (OpenAlex) of 0.70, placing it in the Q3 quartile within the Breast Lesions and Carcinomas research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Diagnostic Cytopathology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Diagnostic Cytopathology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Diagnostic Cytopathology against similar journals in the field, use our journal comparison tool.
Submission Tips for Diagnostic Cytopathology
- Budget $3550 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Breast Lesions and Carcinomas, Cancer and Skin Lesions, Cervical Cancer and HPV Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Diagnostic Cytopathology Compares
Compared against 30 journals in the same research areas.
| ISSN (Print) | 1097-0339 |
|---|---|
| ISSN (Online) | 8755-1039 |
| Publisher | Wiley |
| Country | United States |
| APC / Cost | $3550 USD |
In-depth profile & metrics
Diagnostic Cytopathology is published by Wiley and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3550.
In our subject taxonomy, Diagnostic Cytopathology is classified under Breast Lesions and Carcinomas, Cancer and Skin Lesions, Cervical Cancer and HPV Research and Salivary Gland Tumors Diagnosis and Treatment.
Diagnostic Cytopathology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.699.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Diagnostic Cytopathology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.699 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Diagnostic Cytopathology against similar publications in its field:
Related Journals in Your Field
-
Modern Pathology Elsevier BV IF 5.84
-
Breast Cancer Research BioMed Central IF 4.57
-
Frontiers in Endocrinology Frontiers Media IF 3.97
-
Endocrine Springer Science+Business Media IF 3.12
-
BMC Women s Health BioMed Central IF 3.12
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S23314063
Get weekly updates for Breast Lesions and Carcinomas journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.